Georg Ebersbach

6.7k total citations
140 papers, 4.1k citations indexed

About

Georg Ebersbach is a scholar working on Neurology, Psychiatry and Mental health and Cellular and Molecular Neuroscience. According to data from OpenAlex, Georg Ebersbach has authored 140 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 123 papers in Neurology, 26 papers in Psychiatry and Mental health and 24 papers in Cellular and Molecular Neuroscience. Recurrent topics in Georg Ebersbach's work include Parkinson's Disease Mechanisms and Treatments (111 papers), Neurological disorders and treatments (75 papers) and Botulinum Toxin and Related Neurological Disorders (21 papers). Georg Ebersbach is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (111 papers), Neurological disorders and treatments (75 papers) and Botulinum Toxin and Related Neurological Disorders (21 papers). Georg Ebersbach collaborates with scholars based in Germany, Austria and Sweden. Georg Ebersbach's co-authors include Werner Poewe, Jörg Wissel, Florin Gandor, Angelika Nebe, Daniela Edler, Bastiaan R. Bloem, Nienke M. de Vries, Alexander Storch, M.R. Dimitrijević and Per Odin and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Brain.

In The Last Decade

Georg Ebersbach

132 papers receiving 4.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Georg Ebersbach Germany 34 2.9k 994 745 675 552 140 4.1k
Claire L Tomlinson United Kingdom 14 4.1k 1.4× 1.3k 1.3× 895 1.2× 918 1.4× 493 0.9× 20 4.9k
Tien K. Khoo Australia 33 3.1k 1.1× 736 0.7× 380 0.5× 774 1.1× 642 1.2× 69 4.2k
Smitaa Patel United Kingdom 27 4.9k 1.7× 1.3k 1.3× 966 1.3× 1.0k 1.5× 834 1.5× 50 6.3k
Bart Post Netherlands 24 2.6k 0.9× 871 0.9× 490 0.7× 685 1.0× 442 0.8× 58 3.4k
Eugene C. Lai United States 33 2.3k 0.8× 736 0.7× 411 0.6× 321 0.5× 483 0.9× 83 3.3k
Marianna Amboni Italy 43 4.0k 1.4× 922 0.9× 765 1.0× 1.4k 2.1× 769 1.4× 131 5.7k
Cynthia L. Comella United States 38 4.0k 1.4× 915 0.9× 546 0.7× 1.1k 1.7× 789 1.4× 82 4.9k
Nirav Sheth United States 9 1.8k 0.6× 529 0.5× 481 0.6× 463 0.7× 533 1.0× 9 3.0k
William Zhu United States 10 1.8k 0.6× 494 0.5× 386 0.5× 430 0.6× 524 0.9× 17 2.7k
Marina Picillo Italy 42 4.1k 1.4× 603 0.6× 381 0.5× 991 1.5× 1.1k 2.0× 167 5.2k

Countries citing papers authored by Georg Ebersbach

Since Specialization
Citations

This map shows the geographic impact of Georg Ebersbach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Georg Ebersbach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Georg Ebersbach more than expected).

Fields of papers citing papers by Georg Ebersbach

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Georg Ebersbach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Georg Ebersbach. The network helps show where Georg Ebersbach may publish in the future.

Co-authorship network of co-authors of Georg Ebersbach

This figure shows the co-authorship network connecting the top 25 collaborators of Georg Ebersbach. A scholar is included among the top collaborators of Georg Ebersbach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Georg Ebersbach. Georg Ebersbach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gandor, Florin, Vera D. Jäger, Doreen Gruber, et al.. (2025). Is Dysphagia in Multiple System Atrophy Responsive to Levodopa? Results from a Retrospective Study. Movement Disorders Clinical Practice. 13(3). 683–691.
2.
Löhle, Matthias, Wolfgang H. Jost, Florin Gandor, et al.. (2024). Intercultural Translation and Application of the German Version of King’s Parkinson’s Disease Pain Questionnaire in Fluctuating Parkinson’s Disease. Acta Neurologica Scandinavica. 2024(1). 3 indexed citations
3.
Gandor, Florin, et al.. (2024). Vestibulo-Ocular Reflex Suppression: Clinical Relevance and Assessment in the Digital Age. SHILAP Revista de lepidopterología. 8(1). 52–58.
4.
Löhle, Matthias, et al.. (2023). Agreement between Parkinson Disease Home Diary and Observer Assessments before and after Structured Patient Training. Acta Neurologica Scandinavica. 2023. 1–10. 2 indexed citations
5.
Weiß, Daniel, Georg Ebersbach, Jens Carsten Möller, et al.. (2022). Do we start too late? Insights from the real-world non-interventional BALANCE study on the present use of levodopa/carbidopa intestinal gel in advanced Parkinson's disease in Germany and Switzerland. Parkinsonism & Related Disorders. 103. 85–91. 8 indexed citations
6.
Kübler, Dorothee, Daniel Kroneberg, Bassam Al‐Fatly, et al.. (2021). Determining an efficient deep brain stimulation target in essential tremor - Cohort study and review of the literature. Parkinsonism & Related Disorders. 89. 54–62. 17 indexed citations
7.
Michaelis, R., Norbert Brüggemann, Georg Ebersbach, et al.. (2021). Entwicklung und inhaltliche Validierung eines Fragebogens für funktionelle Bewegungsstörungen. Der Nervenarzt. 93(10). 1009–1018. 1 indexed citations
8.
Gandor, Florin, Hannelore Neuhauser, Doreen Gruber, et al.. (2020). Diagnostic accuracy of a smartphone bedsidetest to assess the fixation suppression of the vestibulo-ocular reflex: when nothing elsematters. Journal of Neurology. 267(7). 2159–2163. 5 indexed citations
9.
10.
Buhmann, Carsten, Tina Mainka, Georg Ebersbach, & Florin Gandor. (2019). Evidence for the use of cannabinoids in Parkinson’s disease. Journal of Neural Transmission. 126(7). 913–924. 30 indexed citations
11.
Gandor, Florin & Georg Ebersbach. (2017). Cannabinoids in the Treatment of Parkinson’s Disease. 1(4). E307–E311. 2 indexed citations
12.
Leplow, Bernd, et al.. (2016). Impaired learning of punishments in Parkinson’s disease with and without impulse control disorder. Journal of Neural Transmission. 124(2). 217–225. 12 indexed citations
13.
Müller, Thomas, Teus van Laar, David R. Cornblath, et al.. (2013). Peripheral neuropathy in Parkinson's disease: Levodopa exposure and implications for duodenal delivery. Parkinsonism & Related Disorders. 19(5). 501–507. 94 indexed citations
14.
Storch, Alexander, Per Odin, Iris Trender‐Gerhard, et al.. (2010). Non-motor Symptoms Questionnaire und Scale für das idiopathische Parkinson-Syndrom. Der Nervenarzt. 81(8). 980–985. 33 indexed citations
15.
Spuler, Simone, Christine Klein, Georg Ebersbach, et al.. (2009). Myopathy causing camptocormia in idiopathic Parkinson's disease: A multidisciplinary approach. Movement Disorders. 25(5). 552–559. 53 indexed citations
16.
Ebersbach, Georg & Alexander Storch. (2008). Tolcapone in elderly patients with Parkinson’s disease: A prospective open-label multicenter non-interventional trial. Archives of Gerontology and Geriatrics. 49(1). e40–e44. 2 indexed citations
17.
Wichniak, Adam, Ferenc Tracik, Peter Geisler, et al.. (2001). Rhythmic feet movements while falling asleep. Movement Disorders. 16(6). 1164–1170. 27 indexed citations
18.
Tracik, Ferenc & Georg Ebersbach. (2001). Sudden daytime sleep onset in Parkinson's disease: Polysomnographic recordings. Movement Disorders. 16(3). 500–506. 62 indexed citations
19.
Ebersbach, Georg, et al.. (1999). Worsening of motor performance in patients with Parkinson's disease following transdermal nicotine administration. Movement Disorders. 14(6). 1011–1013. 63 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Claire L Tomlinson Breakdown of academic impact, for papers by Tien K. Khoo Breakdown of academic impact, for papers by Smitaa Patel Breakdown of academic impact, for papers by Bart Post Breakdown of academic impact, for papers by Eugene C. Lai Breakdown of academic impact, for papers by Marianna Amboni Breakdown of academic impact, for papers by Cynthia L. Comella Breakdown of academic impact, for papers by Nirav Sheth Breakdown of academic impact, for papers by William Zhu Breakdown of academic impact, for papers by Marina Picillo
Rankless by CCL
2026